Perimeter buys Medical Manufacturing Technologies in a $685M deal

Perimeter Solutions has agreed to acquire medical contract manufacturer Medical Manufacturing Technologies (MMT) from private equity firm Arcline Investment Management in a transaction valued at $685 million. The deal, announced on Thursday, reinforces Perimeter’s strategic push into precision device production and is expected to complete in the first quarter of 2026 subject to regulatory clearance.

Headquartered in Charlotte, MMT operates as a specialist supplier to med‑tech original equipment manufacturers and CDMOs, supporting complex interventional products. The company lists more than 1,000 customers, employs roughly 350 people across 14 production facilities, and focuses on components such as catheters, guidewires, stents and microcoils—areas that demand tight process control and regulatory expertise.

Arcline acquired MMT in 2020 and, according to the firm, executed a buy‑and‑build programme that included 13 add‑on acquisitions to broaden automation and specialty manufacturing capabilities. During its hold period Arcline scaled revenue and improved profitability metrics, positioning MMT as a platform asset attractive to a strategic buyer seeking manufacturing depth.

For Perimeter Solutions, the acquisition plugs a manufacturing gap and expands its footprint in regulated device production. Industry consolidation has been accelerating as med‑tech OEMs and CDMOs demand integrated supply chains and partners that can deliver high‑mix, low‑volume production reliably. Analysts estimate the global medical device contract manufacturing market remains in the high single‑digit annual growth range as ageing populations and minimally invasive therapies push demand.

The transaction highlights two broader trends: strategic buyers buying vertical manufacturing capabilities to secure supply and private equity realising exits after scaling niche industrial platforms. For Arcline—an investor with roughly $20 billion in assets under management—the sale represents a monetisation of an industrially focused compounder it built through bolt‑ons and operational improvement.

Advisors on the deal included financial teams at William Blair and Houlihan Lokey; legal counsel for the sellers comprised Kirkland & Ellis LLP and Fredrikson & Byron P.A. Management at MMT, led by CEO Robbie Atkinson, will remain a focal point through integration planning and handover to Perimeter.